WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA
Clinical trials for WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA explained in plain language.
Never miss a new study
Get alerted when new WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA trials appear
Sign up with your email to follow new studies for WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare blood disorder: drug trial targets anemia that Won't quit
Disease control OngoingThis study tests an experimental drug called HMPL-523 for people with warm antibody autoimmune hemolytic anemia, a condition where the immune system destroys red blood cells. The goal is to see if the drug can safely raise hemoglobin levels and control the disease. About 111 adul…
Matched conditions: WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: PHASE2, PHASE3 • Sponsor: Hutchmed • Aim: Disease control
Last updated May 26, 2026 10:46 UTC
-
New hope for anemia in leukemia: targeted drug shows promise
Disease control OngoingThis study tests a drug called acalabrutinib in people with chronic lymphocytic leukemia (CLL) who also have a type of anemia (AIHA) that came back or didn't get better with standard treatment. The drug works by blocking certain enzymes that help cancer cells grow. The main goal …
Matched conditions: WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 22, 2026 13:53 UTC